Interventional device developer Boston Scientific has received the European CE Mark for its Promus everolimus-eluting coronary stent system.
Promus is a private-labeled Xience V everolimus-eluting coronary stent system manufactured by Abbott Vascular and distributed by Boston Scientific. The Natick, MA-based firm said it expects to launch the stent in Europe in 2007.
By AuntMinnie.com staff writers
October 16, 2006
Related Reading
Boston Scientific taps Japp, October 11, 2006
Boston Scientific introduces FlexView, September 20, 2006
Boston Scientific reaches halfway point in drug-eluting stent trial, August 31, 2006
Boston Scientific posts powerful Q2 sales, July 27, 2006
Boston Scientific debuts IVUS unit, July 14, 2006
Copyright © 2006 AuntMinnie.com